| |
 |
Human immunodeficiency virus (HIV) nucleotide sequences |
| 7393949 |
Human immunodeficiency virus (HIV) nucleotide sequences
|
|
| Patent Drawings: | |
| Inventor: |
Luciw, et al. |
| Date Issued: |
July 1, 2008 |
| Application: |
08/443,345 |
| Filed: |
May 17, 1995 |
| Inventors: |
Luciw; Paul A. (Davis, CA)
Dina; Dino (San Francisco, CA)
Steimer; Kathelyn (Benicia, CA)
Pescador; Ray Sanchez (Oakland, CA)
George-Nascimento; Carlos (Danville, CA)
Parkes; Deborah (Oakland, CA)
Hallewell; Rob (San Francisco, CA)
Barr; Philip J. (Oakland, CA)
Truett; Martha (Oakland, CA)
|
| Assignee: |
Novartis Vaccines and Diagnostics, Inc. (Emeryville, CA) |
| Primary Examiner: |
Zeman; Mary K. |
| Assistant Examiner: |
|
| Attorney Or Agent: |
Harbin; Alisa A.Hemmendinger; Lisa |
| U.S. Class: |
536/24.5; 424/184.1; 435/320.1; 435/5; 435/6; 435/69.1; 435/7.1; 436/501 |
| Field Of Search: |
536/23.1; 536/23.72; 536/24.1; 435/5; 435/6 |
| International Class: |
A61K 39/00 |
| U.S Patent Documents: |
|
| Foreign Patent Documents: |
443605; 35 87 394; 0 020 251; 0 060 057; 0 062 574; 0 073 635; 0 088 632; 0 116 201; 0 136 798; 0 138 667; 0 139 216; 0 152 030; 0 165 120; 0 173 529; 0 178 978; 0 181 150; 0 181 150; 0 185 444; 0 187 041; 0 201 540; 0 178 978; 2104902; 84/23659; 84/16013; 84/29099; 85/01473; 85/04897; 85/04903; 86/02383; 86/06414; 84/7005 |
| Other References: |
Manzari et al. 1983 PNAS USA v 80 p. 1574-78, Mar. 1, 1983. cited by examiner.
USSN 728,052, Apr. 29, 1985. cited by other.
USSN 767,303, Aug. 19, 1985. cited by other.
USSN 685,272, Dec. 24, 1984. cited by other.
USSN 844,485, Nov. 13, 1986. cited by other.
Allan et al., Science (1985) 228:1091-1094. cited by other.
Amann et al., Gene (1983) 25:167-178. cited by other.
Barin et al., Science (1985) 228:1094-1096. cited by other.
Beardsley et al., Nature (1984) 311:195. cited by other.
Bolivar et al., Gene (1977) 2:95-113. cited by other.
Brun-Vezinet et al., Lancet (1984) 1253-1256. cited by other.
Casadban et al., J. Bacteriology (1980) 143(2):971-980. cited by other.
Chanda et al., FASEB Proceedings (1985) 44(5):1540. cited by other.
Chang et al., J. Cell. Biochem. (1985) 9A: 81 Abstract 0187. cited by other.
Chang et al., Science (1985) 228:93-96. cited by other.
Chang et al., Nature (1985) 315:151-154. cited by other.
Chang et al., Bio/Technology (1985) 3(10):905-909. cited by other.
Chemical and Engineering News, (1984) p. 7. cited by other.
Chen et al., Nature (1984) 309:276-279. cited by other.
Chen et al., Nature (1983) 305:502-505. cited by other.
Chermann et al., in Gottlieb et al. (eds. 1984) "Acquired Immune Deficiency Syndrome" UCLA Symposia on Molecular Biology, News Series, vol. 16 (1984) pp. 31-46. cited by other.
Clinica, Abstract (1984) p. 9. cited by other.
De Boer et al., Proc. Natl. Acad. Sci. (1983) 80:21-25. cited by other.
DiMaio et al., Proc. Natl. Acad. Sci. (1982) 79:4030-4032. cited by other.
Dina et al., DNA (1985) 4(1):56. cited by other.
Ellrodt et al., Lancet (1984) 1:1383-1385. cited by other.
Fisher et al., Nature (1985) 316:262-265. cited by other.
Fischinger et al., Cancer Research (1985) 45:4694s-4699s. cited by other.
French, T.J., First Declaration of T.J. French (1994). cited by other.
Gallo et al., in Gottlieb et al. Eds. (1984) pp. 47-58 "Acquired Immune Deficiency Syndrome" UCLA Symposia on Molecular Biology, New Series (1984) 16:47-58. cited by other.
Gluzman et al., Cell (1981) 23:175-182. cited by other.
Gnann et al., J. Virology (1987) 61(8):2639-2641. cited by other.
Gray et al., Proc. Natl. Acad. Sci. (1982) 79:6598-6602. cited by other.
Groopman et al., New Eng. J. Med. (1984) 311(22) :1419-1422. cited by other.
Hahn et al., Nature (1984) 312:166-169. cited by other.
Hattori et al., Virology (1984) 136:338-347. cited by other.
Huang et al., DNA (1985) 4(1):70. cited by other.
Karn et al., Meth. Enzymology (1983) 101:3-19. cited by other.
Kitchen et al., Nature (1984) 312:367-369. cited by other.
Kiyokawa et al., Proc. Natl. Acad. Sci. (1984) 81:6202-6206. cited by other.
Levy et al., Ann. Int. Med. (1985) 103:694-699. cited by other.
Liou et al., DNA (1985) 4(1):71. cited by other.
Luciw et al., DNA (1985) 4(1):71. cited by other.
Maniatis et al., Cold Spring Harbor Laboratory "Molecular Cloning" (1982) pp. 406-427. cited by other.
Maxam et al., Methods Enzymol. (1980) 65:499-560. cited by other.
Mellon et al., Cell (1981) 27:279-288. cited by other.
Montagnier et al., Ann. Virol. (1984) 135E:119-134. cited by other.
Montagnier et al., Virology (1985) 144:283-289. cited by other.
Montagnier et al., in Retroviruses in Human Lymphoma/Leukemia (1985) (Miwa et al. Eds) Proceedings of the 15th International Symposium of the Princess Takamatsu Cancer Research Fund, Tokyo (1984) (1985) pp. 319-331. cited by other.
Muesing et al., Nature (1985) 313:450-458. cited by other.
Mulligan et al., Mol. Cell. Biol. 1(5):449-459. cited by other.
New York Times (National Edition), (1984) p. E91. cited by other.
New York Times (National Edition), (1984) p. 11. cited by other.
New York Times (National Edition), (1984) p. 16. cited by other.
Oroszlan et al., PNAS (1982) 79:1291-1294. cited by other.
Ramsay et al., Lancet (1984) pp. 397-398. cited by other.
Ratner et al., Nature (1985) 313:277-284. cited by other.
Robey et al, Science (1985) 228:593-595. cited by other.
Ruther et al., EMBO Journ. (1983) 2:1791-1794. cited by other.
Sanchez-Pescador et al., AIDS, Papers from Sci. (1985) 410-428. cited by other.
San Fransisco Chronicle, front and back pages (Oct. 9, 1984). cited by other.
Sanger et al., PNAS (1977) 74:5463-5467. cited by other.
Sarver et al., Proc. Natl. Acad. Sci., (1982) 79:7147-7151. cited by other.
Sarver et al., Mol. Cell. Biol. (1981) 1:486-496. cited by other.
Schupbach et al., Science (1984) 224:607-610. cited by other.
Schupbach et al., Science (1984) 224:503-506. cited by other.
Seiki et al., PNAS (1982) 79:6899-6902. cited by other.
Seiki et al., PNAS (1983) 80:3618-3622. cited by other.
Shatzman et al., in Experimental Manipulation of Gene Expression (Inouye ed.) (1983) pp. 1-14. cited by other.
Shimitake et al., Nature (1981) 292:128-132. cited by other.
Stanley et al., EMBO Journ. (1984) 3:1429-1434. cited by other.
Starcich et al., Cell (1986) 45:637-648. cited by other.
Towbin et al., Proc. Natl. Acad. Sci. (1979) 76:4350-4354. cited by other.
Wain-Hobson et al. Cell (1985) 40:9-17. cited by other.
Weinstock et al., Proc. Natl. Acad. Sci. (1983) 80:4432-4436. cited by other.
Winnacker et al., Gene and Klone (1984). cited by other.
Wong-Staal et al., Nature (1985) 317:395-403. cited by other.
Cohen et al., J. Hyg., Cambridge, (1984) 93:225-232. cited by other.
Roggendorf et al., J. Viroglical Methods, (1983) 6:61-70. cited by other.
Peutherer et al., Med. Laboratory Sciences, (1981) 38:355-358. cited by other.
Alizon et al., Nature, (1984) 312:757-760. cited by other.
Arya, et al., Science, (1984) 225:927-930. cited by other.
Barre-Sinoussi, et al., Science, (1983) 220:868-871. cited by other.
Chang, et al., Nature, (1985) 315:151-154. cited by other.
Crowl, R., et al., Cell (1985) 41:979-986. cited by other.
Culliton, AIDS: Papers from Science, (1982-1985) 266-277. cited by other.
Fauci, et al., Annals of Internal Medicine, (1984) 100:92-106. cited by other.
Fenyo, et al., AIDS 3 (Suppl. 1):S5-S12 (1989). cited by other.
Feorino, et al., Science, (1984) 225:69-72. cited by other.
Gallo, et al., Science, (1984) 224:500. cited by other.
Gallo, et al., Science, (1984) 224:497-504. cited by other.
Gurgo, et al., Virology, 164:531-536. cited by other.
Ho, et al., Science, (1984) 226:451-453. cited by other.
Kalyanaraman, et al., Science, (1984) 224:321-323. cited by other.
Klatzmann, et al., Science, (1984) 225:59-62. cited by other.
Klatzmann, et al., Nature, (1984) 312:767-768. cited by other.
Lee, et al., Science (1984) 226:57-61. cited by other.
Levy, et al., Science (1984) 225:840-842. cited by other.
Looney, et al., Science (1988) 241:357-359. cited by other.
Luciw, et al., Nature (1984) 312:760-763. cited by other.
Marx, Science, (1984) 224:475-477. cited by other.
Melbye, et al., British Medical Journal (1984) 289:573-575. cited by other.
Meyerhans, A., et al., Cell (1989) 58:901-910. cited by other.
Montagnier, et al., New Retrovirus in LAS and AIDS (1984). cited by other.
Montagnier, et al., Science (1984) 225:63-66. cited by other.
Popovic, et al., Science (1984) 224:497-500. cited by other.
Samuel, et al., Science (1984) 226:1094-1097. cited by other.
Sanchez-Pescador, et al., Science (1985) 227:484-492. cited by other.
Safai, et al., Lancet (1984) 1438-1440. cited by other.
Sarngadharan, et al., Science (1984) 224:506-508. cited by other.
Saxinger, et al., Laboratory Investigation (1983) 49:371-377. cited by other.
Schupback, et al., Science (1984) 224:607-609. cited by other.
Shaw, et al., Science (1984) 226:1165-1171. cited by other.
Shaw, et al., AIDS: Papers from Science, (1982-1985) 356-268. cited by other.
Sinkovics, e al., Reviews of Infectious Diseases (1984) 6:745-760. cited by other.
Vilmer, et al., Lancet (1984) 1:753. cited by other.
Wain-Hobson, S., AIDS 3 (Suppl. 1):S13-S18 (1989). cited by other.
Expert Report of John A. T. Young, Ph.D. cited by other.
Expert Report of B. Matija Peterlin, M.D. cited by other.
Expert Report of Robin A. Weiss, Ph.D. cited by other.
Amended Expert Report of Hans-Martin Jack, Ph.D. cited by other.
Expert Report of Herman N. Eisen, Ph.D. cited by other.
Original Notice of Opposition by Abbott Laboratories filed Jun. 11, 1993. cited by other.
Supplemental version of original Notice of Opposition by Abbott filed Mar. 9, 1994. cited by other.
Notice of Opposition (plus English translation) by Biotest AG filed Mar. 3, 1994. cited by other.
Notice of Opposition (plus English translation) by Hoffman-La Roch AG filed Mar. 7, 1994. cited by other.
Notice of Opposition by British Bio-Technology Ltd., filed Mar. 8, 1994. cited by other.
Notice of Opposition by Murex Diagnostics Ltd., filed Mar. 8, 1994. cited by other.
Notice of Opposition by Akzo Pharma BV filed Mar. 9, 1994. cited by other.
Notice of Opposition by Viagene Inc., filed Mar. 9, 1994. cited by other.
Notice of Opposition (plus English translation) by Behringwerke filed Mar. 9, 1994. cited by other.
Notice of Opposition by Immuno AG filed Mar. 9, 1994. cited by other.
Response to Oppositions by Chiron filed Jul. 11, 1995. cited by other.
Observations by British Bio-Technology Ltd., filed Jan. 25, 1996. cited by other.
Amended Memorandum and Order Re Defense of Enablement by U.S. District Court Judge Marilyn Patel entered Apr. 25, 1996. cited by other.
Memorandum and Order Re: Inequitable Conduct and Prior Invention by U.S. District Court Judge Marilyn Patel entered Sep. 19, 1995. cited by other.
Translation of Action for Grant of Compulsory License to EP 0 181 150, Jul. 3, 2000. cited by other.
Interlocutory Decision in Opposition Proceedings 85 307 860.8, Mar 10, 1998 (English translation, Exhibit K2, filed in compulsory license action [D3]). cited by other.
Interlocutory Decision in Opposition Proceedings 85 307 860.8, Mar 10, 1998 (original German, Exhibit K2a, filed in compulsory license action [D3]). cited by other.
Documents submitted to EPO by Chiron for maintaining EP 0 181 150 (Exhibit K3 filed in compulsory license action [D3]), 2002. cited by other.
Minutes of Oral Proceedings in T351/98-334, Nov. 2, 3, and 4, 1999 (Exhibit K4 filed in compulsory license action [D3]). cited by other.
Main Request and four auxiliary requests (Exhibit K5 filed in compulsory license action [D3]), 2002. cited by other.
Rompp's Lexikon der Chemie, 10.sup.th ed., Stuttgart/New York, 1999 (Exhibit K6 filed in compulsory license action [D3]). cited by other.
Rompp's Lexikon der Biotechnologie und Gentechnik, 2d ed., Stuttgart/New York, 1999 (Exhibit K7 filed in compulsory license action [D3]). cited by other.
Product description of Amplicor HIV-1 Monitor.TM. Test, Version 1.5, Nov. 1998 (Exhibit K8 filed in compulsory license action [D3]). cited by other.
Product description of COBAS HIV-1 Monitor.TM. Test, version 1.5, May 1999 (Exhibit K9 filed in compulsory license action [D3]). cited by other.
Product description of Amplicor.RTM. HIV-1 Test, Aug. 1998 (Exhibit K10 filed in compulsory license action [D3]). cited by other.
Expert opinion by Prof. Dr. med. Lutz Gurtler (Exhibit K11 filed in compulsory license action [D3]), 2002. cited by other.
Erice et al., Performance Characteristics of the bDNA 3.0 Assay for Quantitation of HIV-1 RNA in Plasma, Poster Session (Exhibit K12 filed in compulsory license action [D3]), 2002. cited by other.
Roland et al., Pitfalls of HIV RNA testing in the San Francisco Post-Exposure Prevention Project, presented at the 6.sup.th Conference on retroviruses and Opportunistic Infections (Chicago, Feb. 1999) (Exhibit K13 filed in compulsory license action[D3]). cited by other.
Perez et al., Evaluation of the New Quantiplex 3.0 HIV bDNA Asay (Q3): A comparison with Quantiplex 2.0 (Q2), presented at the 6.sup.th Conference on retroviruses and Opportunistic Infections (Chicago, Feb. 1999) (Exhibit K14 filed in compulsorylicense action [D3]). cited by other.
Decision of the 4.sup.th Division for Civil Matters of the Regional Court Dusseldorf pronounced May 18, 2000 (original German, Exhibit K15 filed in compulsory license action [D3]). cited by other.
Decision of the 4.sup.th Division for Civil Matters of the Regional Court Dusseldorf pronounced May 18, 2000 (English translation of Exhibit K15 filed in compulsory license action [D3]). cited by other.
Letter to William Green, Chiron Corporation, dated Jun. 2, 1999 (Exhibit K16 filed in compulsory license action [D3]). cited by other.
Letter to William Green, Chiron Corporation, dated May 19, 2000 (Exhibit K17 filed in compulsory license action [D3]). cited by other.
HIVS/AIDS/STI Surveillance, http://www.who.int/health.topics/hiv.htm, '00 (Exhibit K18 filed in compulsory license action [D3]). cited by other.
Allgemeines zu den epidemiologischen Seiten uber HIV/AIDS, Robert Koch-Institut, 1999 (Exhibit K19 filed in compulsory license action [D3]). cited by other.
Remarks as prepared for delivery by Vice President Al Gore, United Nations Security Council Opening Session, Jan. 10, 2000 (Exhibit K20 filed in compulsory license action [D3]). cited by other.
Statement by Dr. Andreas Plettenberg, HAART 1998--Moglichkeiten und Grenzen, 1998 (Exhibit K21 filed in compulsory license action [D3]). cited by other.
Declaration by Prof. Dr. med. Noll (Exhibit K22 filed in compulsory license action [D3]), 2002. cited by other.
Declaration of Prof. Dr. Petersen (Exhibit K23 filed in compulsory license action [D3]), 2002. cited by other.
Declaration by the joint practice of Dr. med. Knechten, Dr. med Habetz dated Jun. 5, 2000 (Exhibit K24 filed in compulsory license action [D3]). cited by other.
Declaration of Michael P. Dooley, Oct. 3, 1991, filed in Chiron Corporation v. Roche Nederland B.V. et al., Case No. 98/870. cited by other.
Declaration of Joseph M. Perillo, 1999, filed in Chiron Corporation v. F. Hoffmann-La Roche AG et al., Case No. 7 0 21945/97. cited by other.
Statement of Claim dated Nov. 27, 1997, Certified Copy of Court Directions dated Dec. 3, 1997, and copy of decision dated Dec. 3, 1997 in Case No. 7 0 21945/97 (Action for a Negative Declaration). cited by other.
Decision on Preliminary Motions in Interference No. 103,659, 2002. cited by other.
Reconsideration of Decision on Preliminary Motions in Interference No. 103,659, 2002. cited by other.
Decision on Preliminary Motions, Interference No. 105,291, Sep. 1, 2006. cited by other.
Decision on Preliminary Motions, Interference No. 105,289, Sep. 1, 2006. cited by other.
U.S. Appl. No. 07/999,410, filed Dec. 31, 1992, Alizon. cited by other.
U.S. Appl. No. 06/558,109, filed Dec. 5, 1983, Montagnier. cited by other.
U.S. Appl. No. 06/659,339, filed Oct. 10, 1984, Chang. cited by other.
U.S. Appl. No. 06/643,306, filed Aug. 22, 1984, Wong-Staal. cited by other.
Abstracts of Papers, Cold Spring Harbor Laboratory, "RNA Tumor Viruses," May 22-May 27, 1984. cited by other.
Abstracts of Papers; Cold Spring Harbor Laboratory, "Human T-cell Leukemia Viruses," Sep. 14-Sep 15, 1983. cited by other.
Aoki et al., "Location Of Human T-cell Leukemia Virus (HTLV) P19 Antigen On HTLV-Producing Cells And A Role Of Natural Antibody To HTLV-Related Antigens In Antibody-Dependent Cell-Mediated Cytotoxicity Against HTLV-Producing Cells." Cold SpringHarbor meeting on "Human T-Cell Leukemia Viruses," held Sep. 14 to Sep. 15, 1983. cited by other.
Arima, N. et al., "Human T-Cell Leukemia Virus Type 1 Tax Induces Expression of the Rel-Related Family of kB Enhancer-Binding Proteins: Evidence for a Pretranslational Component of Regulation" Journal of Virol. 65:6892-6899 (Dec. 1991). cited byother.
Blattner et al., "Epidemiology of HTLV-Associated Leukemia" in Modern Trends in Human Leukemia V, Berlin, Springer-Verlag (1983), p. 148-155. cited by other.
Blattner et al., "HTLV: Epidemiology And Relationship To Human Malignancy," Cold Spring Harbor meeting on "Human T-Cell Leukemia Viruses," held Sep. 14 to Sep. 15, 1983. cited by other.
Catovsky et al., "Adult T-cell lymphoma-leukaemia in Blacks from the West Indies" Lancet 1(8273):639-43 (1982). cited by other.
Essex, M. et al., "Antibodies to Human T-Cell Leukemia Virus Membrane Antigens (HTLV-MA) in Hemophiliacs," Science 221: 1061-1064 (1983). cited by other.
Gallo and Reitz, "Human Retroviruses and Adult T-Cell Leukemia-Lymphoma," J. Natl. Cancer Inst. 69(6): 1209-1214 (1982). cited by other.
Gallo et al., "Effects of Human T-cell lymphoma (leukemia) virus and T-Cell growth factor on human T cells," in Expression of Differentiated Functions in Cancer Cells, New York, Raven Press, 1982, p. 191-205. cited by other.
Gallo et al., "Interaction of T-cell growth factor and a new retrovirus (HTLV) with human T cells" in Differentiation and function of hematopoetic cell surfaces, vol. 1, UCLA Symposia on Molecular and Cellular Biology, New York, Alan R. Liss, 1982,p. 231-246. cited by other.
Gallo et al., "Origin of human T-cell leukaemia-lymphoma virus" Lancet ii:962-963 (1983). cited by other.
Gallo et al., "Isolation of Human T-Cell Leukemia Virus in Acquired Immune Deficiency Syndrome (AIDS)," Science 200, 865-67, May 1983. cited by other.
Gelmann et al., "A New Human Retrovirus Associated With A T-Cell Hairy Cell Leukemia, Cloning And Characterization Of HTLV-11.sub.(Mo)," Cold Spring Harbor meeting on "Human T-Cell Leukemia Viruses," held Sep. 14 to Sep. 15, 1983. cited by other.
Gelmann et al., "Proviral DNA of a retrovirus, human T-cell leukemia virus, in two patients with AIDS," Science 220 (4599):862-5 (May 1983). cited by other.
Gelmann et al., "Molecular cloning of a unique T-cell leukemia virus (HTLV-II.sub.MO)," Proc. Nat'l Acad. Sci. USA 81:993-997 (1984). cited by other.
Greaves et al., "HTLV In Immigrants To The U.K," Cold Spring Harbor meeting on "Human T-Cell Leukemia Viruses," held Sep. 14 to Sep. 15, 1983. cited by other.
Hahn et al., "Detection and characterization of HTLV-II provirus in a patient with AIDS" In Acquired Immune Deficiency Syndrome (Alan R. Liss, Inc., 150 Fifth Avenue, New York, NY 10011) pp. 73-81 (1984). cited by other.
Hahn et al., "Molecular biology of HTLV in AIDS: II. Isolation and characterization of HTLV-II provirus in a patient with AIDS" J. Cell Biochem. Suppl. 8A:20 (1984). cited by other.
Haseltine et al., "Structure of 3' Terminal Region of Type II Human T Lymphotropic Virus: Evidence for New Coding Region," Science 225(4660):419-421 (Jul. 1984). cited by other.
Haynes et al., "Monoclonal Antibodies Against Human T-cell Leukemia Virus (HTLV) p24 Internal Core Protein And HTLV-Associated p19 Protein Identify Antigens In Normal Human Tissue," Cold Spring Harbor meeting on "Human T-Cell Leukemia Viruses," heldSep. 14 to Sep. 15, 1983. cited by other.
Kalyanaraman et al., "Antibodies in human sera reactive against an internal structural protein of human T-cell lymphoma virus," Nature 294:271-273 (1981). cited by other.
Kalyanaraman et al., "Natural antibodies to the structural core protein (p24) of the human T-cell leukemia (lymphoma) retrovirus found in sera of leukemia patients in Japan" Proc. Natl. Acad. Sci. USA 79(5): 1653-7 (1982). cited by other.
Kalyanaraman et al., "Immunological properties of a type C retrovirus isolated from cultured human T-lymphoma cells and comparison to other mammalian retroviruses," J. Virol. 38:906-915 (1981). cited by other.
Kalyanaraman, V.S. et al., "A New Subtype of Human T-Cell Leukemia Virus (HTLV-II) Associated with a T-Cell Variant of Hairy Cell Leukemia," Science 218:571-73 (Nov. 1982). cited by other.
Kobayashi et al., "Genomic structure of HTLV (human T-cell leukemia virus): detection of defective genome and its amplification in MT-2 cells," EMBO Journal, vol. 3, No. 6, 1339-1343 (1984). cited by other.
Mann et al., "HTLV-Infected B-Cell Lines Established From Patients With Adult T-Cell Leukemias," Cold Spring Harbor meeting on "Human T-Cell Leukemia Viruses," held Sep. 14 to Sep. 15, 1983. cited by other.
Manzari et al., "A rapid and sensitive assay for proviral sequences of a human retrovirus (HTLV) in leukemic cells" Leuk Res. 7:681-686 (1983). cited by other.
Manzari et al., "Abundant transcription of a cellular gene in T-cells infected with human T-cell leukemia/lymphoma virus (HTLV)" Proc. Natl. Acad. Sci. USA 80:11-15 (1983). cited by other.
Manzari et al., "Human T-cell leukemia/lymphoma virus (HTLV): Cloning of an integrated defective provirus and flanking cellular sequences," Proc. Natl. Acad. Sci. USA 80, 1574-78, 1983. cited by other.
Mituya et al., "Cytotoxic T Cells Specific For Human T-cell Leukemia Virus (HTLV)," Cold Spring Harbor meeting on "Human T-Cell Leukemia Viruses," held Sep. 14 to Sep. 15, 1983. cited by other.
Mullins et al., "HTLV Sequences In Leukemias And In ADS," Cold Spring Harbor meeting on "Human T-Cell Leukemia Viruses," held Sep. 14 to Sep. 15, 1983. cited by other.
Ohtsuka et al., "Total Synthesis of a RNA Molecule with sequence identical to that of Escherirchia coli formylmethionine tRNA," Proc. Nat'l Acad. Sci. USA 78(9):5493-5497 (Sep. 1981). cited by other.
Oroszlan et al., "Chemical Analysis of Human T-cell Leukemia Virus (HTLV) Structural Proteins," Cold Spring Harbor meeting on "Human T-Cell Leukemia Viruses" held Sep. 14 to Sep. 15, 1983. cited by other.
Poiesz, B. et al., "Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sezary T-cell leukemia," Nature, 294 (5838):268-71 (Nov. 1981). cited by other.
Poiesz, B.J. et al., "Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma," Proc. Natl Acad. Sci. USA 77:7415-7419 (Dec. 1980). cited by other.
Popovic et al., "Infection And Transformation Of Human T Cells By Human Leukemia/Lymphoma Virus (HTLV)," Cold Spring Harbor meeting on "Human T-Cell Leukemia Viruses," held Sep. 14 to Sep. 15, 1983. cited by other.
Popovic et al., "Isolation and transmission of Human Retrovirus (Human T-Cell leukemia Virus)," Science 219:856-859 (Feb. 1983). cited by other.
Popovic et al., "The virus of Japanese adult T-cell leukaemia is a member of the human T-cell leukaemia virus group" Nature 2300(5887):63-6 (1982). cited by other.
Popovic et al., "Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS," Science 224(4648):497-500 (May 1984). cited by other.
Posner et al., "Natural antibodies to the human T cell lymphoma virus in patients with cutaneous T cell lymphomas," J. Exp. Med. 154:333-346 (1981). cited by other.
Reitz et al., "Characterization and distribution of nucleic acid sequences of a novel type C retrovirus isolated from neoplastic human T lymphocytes," Proc. Natl. Acad. Sci. USA 78:1887-1891 (1981). cited by other.
Reitz et al., "HTLV and HLA Antigen Expression," Cold Spring Harbor meeting on "Human T-Cell Leukemia Viruses," held Sep. 14 to Sep. 15, 1983. cited by other.
Reitz et al., "Presence of HTLV in a Subset of T Cells from an Infected Patient: Some Immunochemical Properties of the Infected Cells" in Modern Trends in Human Leukemia V, Berlin, Springer-Verlag (1983), p. 459-461. cited by other.
Reitz, M. et al., "Primate type-C virus nucleic acid sequences (woolly monkey and baboon types) in tissues from a patient with acute myelogenous leukemia and in viruses isolated from cultured cells of the same patient," Proc. Nat'l. Acad. Sci. USA73:2113-2117 (Jun. 1976). cited by other.
Rho et al., "Characterization of the reverse transcriptase from a new retrovirus I (HTLV) produced by a human cutaneous T-cell lymphoma cell line," Virology 112(1):355-60 (1981). cited by other.
Robert-Guroff et al., "Detection of the human T cell lymphoma virus p19 in cells of some patients with cutaneous T cell lymphoma and leukemia using a monoclonal antibody," J. Exp. Med. 154:1957-1964 (1981). cited by other.
Robert-Guroff et al., "Evidence for human T-cell lymphoma-leukemia virus I infection of family members of human T-cell lymphoma-leukemia virus- positive T-cell leukemia-lymphoma patients" J. Exp. Med. 157(1):248-258 (Jan. 1983). cited by other.
Robert-Guroff et al., "Natural antibodies to the human retrovirus HTLV in a cluster of Japanese patients with adult T-cell leukemia" Science 215(4535):975-978 (Feb. 1982). cited by other.
Robert-Guroff et al., "Sero-Epidemiologic Studies on HTLV-I," Cold Spring Harbor meeting on "Human T-Cell Leukemia Viruses" held Sep. 14 to Sep. 15, 1983. cited by other.
Robert-Guroff et al., Identification of HTLV p19 specific natural antibodies by competition with monoclonal antibody, Virology 122, 297-305, Oct. 1982. cited by other.
Salahuddin et al., "Restricted expression of human T-cell leukemia/lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes" Virology 129:51-64 (1983). cited by other.
Sarngadharin et al., "Immunological Characterization of the Natural Antibodies to Human T-cell Leukemia Virus in Human Sera" in Modern Trends in Human Leukemia V, Berlin, Springer-Verlag (1983), p. 498-503. cited by other.
Saxinger et al., "HTLV: Seroepidemiological Studies In Diverse Populations." Cold Spring Harbor meeting on "Human T-Cell Leukemia Viruses," held Sep. 14 to Sep. 15, 1983. cited by other.
Seigel et al., "On The Dynamic Nature Of Proviral Integration In HTLV Infected Malignancies: A Genetic Analysis," Cold Spring Harbor meeting on "Human T-Cell Leukemia Viruses," held Sep. 14 to Sep. 15, 1983. cited by other.
Shaw et al., "Molecular biology of HTLV in AIDS: I. Molecular cloning of a new HTLV provirus (HTLV-Ib) with divergence in the envelope and pX regions" J. Cell Biochem. Suppl. 8A:20 (1984). cited by other.
Shaw et al., "Molecular biology of human T-cell leukemia virus (HTLV) in acquired immune deficiency syndrome (AIDS)" Clinical Research 32:509A (1984). cited by other.
Shaw et al., "Molecular cloning and analysis of different human T- lymphotropic retroviruses from patients with AIDS or T-cell malignancy" In Acquired Immune Deficiency Syndrome (Alan R. Liss, Inc., 150 Fifth Avenue, New York, NY 10011) pp. 59-72(1984). cited by other.
Shaw et al., "Genomes of Evolutionarily divergent members of the human T-cell leukemia virus family (HTLV-I and HTLV-II) are highly conserved, especially in pX," Proc. Nat'l Acad. Sci. USA 81:4544-48 (1984). cited by other.
Shaw, G. et al., "Human T-Cell Leukemia Virus: Its Discovery and Role in Leukemogenesis and Immunosupression," Year Book Medical Publishers, Inc. (1984). cited by other.
Shimotohno et al., "Nucleotide sequence analysis of the long terminal repeat of human T-cell leukemia virus type II," Proc. Nat'l Acad. Sci. USA 81:1079-83 (Feb. 1984). cited by other.
Sodroski J. et al., "Sequence of the Envelope Glycoprotein Gene of Type II Human T Lymphotrophic Virus," Science 225(4660):421-424 (Jul. 1984). cited by other.
Sodroski, J. et al., "Repetitive structure in the long-terminal-repeat element of a type II human T-Cell leukemia virus," Proc. Natl Acad. Sci. USA, 81:4617-4621 (Aug. 1984). cited by other.
Weiss "Retroviruses linked with AIDS" Nature 309: 12-13 (May 3, 1984). cited by other.
Weiss et al., eds., RNA Tumor Viruses: Molecular Biology of Tumor Viruses, Second Ed., pp. 261-320, Cold Spring Harbor Laboratory (1982). cited by other.
Wong-Staal et al., "A survey of human leukaemias for sequences of human retroviruses" Nature 302:626-628 (1982). cited by other.
Wong-Staal et al., "Integration And Expression Of HTLV Genomes In Fresh And Cultured T-Cells Of Adult T-Cell Leukemia Patients," Cold Spring Harbor meeting on "Human T-Cell Leukemia Viruses," held Sep. 14 to Sep. 15, 1983. cited by other.
Yoshida et al., "Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease," Proc. Nat'l Acad. Sci. USA 79:2031-35 (1982). cited by other.
Decision on Priority, Interference No. 105.291 (Luciw v. Chang). Sep. 28, 2007. cited by other.
Judgement on the Merits, Interference No. 105,291 (Luciw v. Chang), Sep. 28, 2007. cited by other. |
|
| Abstract: |
Polynucleotide sequences are provided for the diagnosis of the presence of retroviral infection in a human host associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome, for expression of polypeptides and use of the polypeptides to prepare antibodies, where both the polypeptides and antibodies may be employed as diagnostic reagents or in therapy, e.g., vaccines and passive immunization. The sequences provide detection of the viral infectious agents associated with the indicated syndromes and can be used for expression of antigenic polypeptides. |
| Claim: |
The invention claimed is:
1. A single-stranded nucleic acid probe comprising a sequence of at least 20 contiguous bases, wherein the at least 20 bases are fully complementary to at least 20contiguous bases selected from the gag, pol, or env open reading frame as shown in FIG. 4 or the complement thereof, said probe not forming a duplex with HTLV-I and -II genomic sequences under conditions of stringency for hybridization under which saidprobe forms a duplex with either strand of viral DNA from a lambda bacteriophage selected from the group consisting of ATCC Accession number 40143 and 40144.
2. The probe of claim 1 wherein the open reading frame is the gag open reading frame wherein the gag open reading frame extends from nucleotide 792 to 2298 of FIG. 4.
3. The probe of claim 1 wherein the open reading frame is pol open reading frame wherein the pol open reading frame extends from nucleotide 2967 to 5103 of FIG. 4.
4. The probe of claim 1 wherein the probe comprises RNA.
5. The probe of claim 1 wherein the probe comprises DNA.
6. The probe of claim 2 wherein the probe comprises RNA.
7. The probe of claim 2 wherein the probe comprises DNA.
8. The probe of claim 3 wherein the probe comprises RNA.
9. The probe of claim 3 wherein the probe comprises DNA.
10. The probe of claim 1 wherein the open reading frame is the env open reading frame, wherein the env open reading frame extends from nucleotide 6235 to 8799 of FIG. 4.
11. The probe of claim 10 wherein the probe comprises RNA.
12. The probe of claim 10 wherein the probe comprises DNA.
13. The probe of claim 1 further comprising a label.
14. The probe of claim 2 further comprising a label.
15. The probe of claim 3 further comprising a label.
16. The probe of claim 4 further comprising a label.
17. The probe of claim 5 further comprising a label.
18. The probe of claim 6 further comprising a label.
19. The probe of claim 7 further comprising a label.
20. The probe of claim 8 further comprising a label.
21. The probe of claim 9 further comprising a label.
22. The probe of claim 10 further comprising a label.
23. The probe of claim 11 further comprising a label.
24. The probe of claim 12 further comprising a label. |
| Description: |
|
|
|
|
